Financial impact of hidradenitis suppurativa on family income and expenditures: a case–control study of out‐of‐pocket catastrophic costs

Documenti analoghi

• Out‐of‐pocket expenses of hidradenitis suppurativa: A cross‐sectional study
  di: M. Delage‐Toriel, et al.
  Pubblicazione: (2025)
• Genomic and proteomic insights into hidradenitis suppurativa
  di: Maria Argyropoulou, et al.
  Pubblicazione: (2026)
• Australasian hidradenitis suppurativa management guidelines
  di: John Frew, et al.
  Pubblicazione: (2024)
• Characterizing financial risk from out‐of‐pocket expenditures across dementia stages
  di: Patricia G. Synnott, et al.
  Pubblicazione: (2025)
• Financial impact on social security of the incorporation of adalimumab for the treatment of hidradenitis suppurativa: An analysis of the 61‐million‐contributor Brazilian Social Security System (INSS)
  di: Luiza Ferreira Vieira d'Almeida, et al.
  Pubblicazione: (2024)